Skip to main content

Inmune Bio, Inc.

INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711754

No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Inmune Bio, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of INMB: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders8279−3
Shares6.17M5.63M−538.8K (−8.7%)
Value$48.1M$12.7M−$35.4M (−73.6%)

New holders (19)

Institutions that held Inmune Bio, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to INMB in Q2 2025
InstitutionSharesValue% of portfolio
Scientech Research LLC45,737$105.7K0.03%
LPL Financial LLC43,172$99.7K0.00%
Virtu Financial LLC40,231$93.0K0.00%
The PNC Financial Services Group, Inc.37,715$87.1K0.00%
GTS Securities LLC35,629$82.3K0.00%
Cubist Systematic Strategies, LLC26,743$61.8K0.00%
Atom Investors LP22,540$52.1K0.00%
Oxford Asset Management LLP22,490$52.0K0.02%
Alliancebernstein L.P.21,950$50.7K0.00%
Modera Wealth Management, LLC15,455$35.7K0.00%
PFG Investments, LLC11,500$26.6K0.00%
Flputnam Investment Management Co11,487$26.5K0.00%
Intech Investment Management LLC11,327$26.2K0.00%
Mariner, LLC10,879$25.1K0.00%
Sculptor Capital LP10,400$24.0K0.00%
Davenport & Co LLC10,000$23.1K0.00%
Point72 (DIFC) Ltd2,120$4.90K0.00%
Union Bancaire Privee, UBP SA1,000$4.55K0.00%
Skopos Labs, Inc.90$2080.00%

Sold out (22)

Institutions that held Inmune Bio, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.